FDA Approves Injectable Dosage Form for Flunixin Meglumine in Horses

Summary

The FDA is updating its regulations to reflect the approval of a new animal drug application for flunixin meglumine injection, which can be administered intravenously or intramuscularly to treat inflammation and pain in horses with musculoskeletal disorders and colic.